Pressure Ulcers Treatment - Global Strategic Business Report

The global market for Pressure Ulcers Treatment was valued at US$5.4 Billion in 2024 and is projected to reach US$6.7 Billion by 2030, growing at a CAGR of 3.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Pressure Ulcers Treatment market.

Global 'Pressure Ulcers Treatment' Market - What’s Fueling the Surge in Demand?

Is Rising Chronic Illness Changing the Dynamics of Pressure Ulcer Management?

The increasing global burden of chronic conditions such as diabetes, obesity, and cardiovascular disease is a primary factor elevating the risk of pressure ulcers, thereby expanding the need for effective treatment solutions. These conditions impair mobility and circulation, leading to prolonged hospital stays and the need for long-term care - both of which are high-risk environments for the development of pressure sores. As healthcare systems face mounting pressure to manage aging populations, the incidence of pressure ulcers continues to climb, especially among elderly patients in nursing homes and immobile individuals in intensive care units. This rising demand has pushed manufacturers to innovate and expand their portfolios, offering a wide range of treatment options that include antimicrobial dressings, advanced foam dressings, negative pressure wound therapy (NPWT) devices, and skin substitutes. Governments and health agencies, particularly in Europe and North America, have also been introducing reimbursement policies and preventive care guidelines to improve outcomes and reduce costs associated with pressure ulcer complications. With the growing emphasis on evidence-based clinical practices, hospitals are adopting integrated wound care systems, further transforming the treatment landscape. This clinical need is also stimulating academic and industrial research, leading to breakthroughs in biomaterials, tissue engineering, and wound monitoring technologies.

Can Technology and Innovation Reshape the Way Pressure Ulcers Are Treated?

Emerging technologies are at the forefront of the transformation occurring in the pressure ulcers treatment market. Innovations such as smart dressings embedded with sensors to monitor pH levels, temperature, and moisture in wounds are significantly enhancing patient outcomes by enabling real-time tracking and early intervention. Likewise, developments in negative pressure wound therapy (NPWT) systems have introduced portable, user-friendly, and cost-efficient models, making outpatient care more feasible. The integration of AI and machine learning in wound assessment tools is further streamlining diagnosis and treatment planning, reducing the time healthcare professionals need to determine the appropriate course of action. Additionally, the growth of telehealth services, particularly accelerated by the COVID-19 pandemic, is now playing a crucial role in monitoring chronic wounds remotely, minimizing hospital visits for vulnerable patients. Startups and established medtech firms alike are increasingly investing in R&D to capitalize on these advancements, giving rise to collaborations with healthcare institutions for clinical trials and product validation. Novel therapies such as stem cell applications and bioengineered skin grafts are also gaining traction, offering alternative solutions for patients with severe or non-healing ulcers. Overall, the infusion of digital and regenerative technologies is rapidly redefining the clinical paradigm for pressure ulcer treatment.

Are Shifting Healthcare Settings and End-User Expectations Driving Change?

Changes in healthcare delivery models and patient expectations are significantly influencing the market. There is a noticeable transition from hospital-centric treatment to home care and outpatient settings, driven by the increasing availability of portable treatment devices and home-use dressings. This shift is not only reducing treatment costs but also empowering patients to take a more active role in their wound care. Moreover, caregivers and healthcare providers are becoming more discerning about the efficacy, ease of use, and safety of treatment products. As a result, there is heightened demand for dressings that promote faster healing with fewer dressing changes, and for products that minimize the risk of infection. The expanding role of pharmacists and community nurses in administering wound care is also boosting the consumption of advanced wound care products outside traditional clinical settings. In addition, the role of private and public insurance providers is evolving, with broader coverage for advanced therapies encouraging their adoption. Regional disparities, however, remain notable - with developed countries benefiting from structured healthcare infrastructure and reimbursement systems, while developing nations face constraints due to high costs and limited access. Nevertheless, awareness campaigns, training programs for caregivers, and government initiatives are gradually bridging these gaps, promoting standardized and timely treatment for pressure ulcers across various demographics and healthcare environments.

The Growth in the Pressure Ulcers Treatment Market Is Driven by Several Factors…

Technological advancements in wound care solutions are among the primary drivers of market expansion. The integration of sensor-enabled dressings, machine learning for wound analysis, and portable NPWT systems is creating new standards for treatment efficiency and accuracy. From an end-use perspective, the increasing demand in long-term care facilities, rehabilitation centers, and home healthcare services is expanding the commercial footprint of pressure ulcer treatment solutions. Changing patient demographics, particularly the rapid growth of the geriatric population, is contributing to higher incidence rates and consequently, a greater need for ongoing wound management. Furthermore, evolving consumer behavior - highlighted by growing awareness about early intervention and product quality - is influencing product development and marketing strategies. Hospital procurement practices are also undergoing transformation, with greater preference for cost-effective, clinically proven, and scalable treatment options. Additionally, regional healthcare reforms, such as value-based care models and incentivized prevention measures, are reshaping purchasing dynamics and care protocols. Competitive dynamics are further intensifying as key players invest heavily in R&D and pursue mergers or strategic partnerships to expand their geographic reach and innovation pipeline. These combined forces - technological innovation, end-user shifts, regulatory momentum, and consumer-centric trends - are powering the sustained and diversified growth of the global pressure ulcers treatment market.

Report Scope

The report analyzes the Pressure Ulcers Treatment market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments: Product Type (Wound Care Dressings, Active Wound Care Therapies, Wound Care Devices); End-User (Hospitals, Community Health Centers, Homecare Centers, Other End-Users).

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Wound Care Dressings segment, which is expected to reach US$3.9 Billion by 2030 with a CAGR of a 3.4%. The Active Wound Care Therapies segment is also set to grow at 4.3% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $1.5 Billion in 2024, and China, forecasted to grow at an impressive 7.0% CAGR to reach $1.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Pressure Ulcers Treatment Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Pressure Ulcers Treatment Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Pressure Ulcers Treatment Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as 3M, Acelity L.P. Inc., Advancis Medical UK Ltd., B. Braun Melsungen AG, Baxter International Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 34 companies featured in this Pressure Ulcers Treatment market report include:

• 3M
• Acelity L.P. Inc.
• Advancis Medical UK Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• Cardinal Health, Inc.
• Coloplast A/S
• ConvaTec Group plc
• Derma Sciences, Inc.
• Essity Aktiebolag (AB)
• Hollister Incorporated
• Integra LifeSciences Corporation
• Medline Industries, Inc.
• Medtronic plc
• Mölnlycke Health Care AB
• MPM Medical, Inc.
• Paul Hartmann AG
• Smith & Nephew plc
• Stryker Corporation
• Urgo Medical

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What's Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry